Evidence map›Paper›PMID 40445892›Full record

ArticlePLOS global public health2025

Socio-medical factors associated with neurodevelopmental disorders on the Kenyan coast.

Patricia Kipkemoi, Jeanne E Savage, Joseph Gona, Kenneth Rimba, Martha Kombe, Paul Mwangi, Collins Kipkoech, Eunice Chepkemoi, Alfred Ngombo, Beatrice Mkubwa and 7 more

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Patricia KipkemoiNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.ORCID https://orcid.org/0000-0003-4622-0749
Jeanne E SavageComplex Trait Genetics Department, Center for Neurogenomics and Cognitive Research (CNCR) Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Joseph GonaNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Kenneth RimbaNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Martha KombeNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Paul MwangiNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Collins KipkoechNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Eunice ChepkemoiNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Alfred NgomboNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Beatrice MkubwaInstitute for Human Development, Aga Khan University, Nairobi, Kenya.
Constance RehemaNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Symon M KariukiNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Danielle PosthumaComplex Trait Genetics Department, Center for Neurogenomics and Cognitive Research (CNCR) Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Kirsten A DonaldDepartment of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and University of Cape Town, Rondebosch, South Africa.ORCID https://orcid.org/0000-0002-0276-9660
Elise RobinsonThe Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Amina AbubakarNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Charles R NewtonNeuroscience Unit, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Funding

Rare genetic disorders in NeuroDev: Insight into the genetic and phenotypic heterogeneity of ID, ASD and ADHD in South African PopulationsU01MH119689 · NIMH · BROAD INSTITUTE, INC. · PI DONALD, KIRSTY, O'DONNELL-LURIA, ANNE · 2019 to 2023
$5.2M
NeuroDev Kenya: characterizing the epidemiology and etiology of developmental disorders on the Kenyan CoastR01HD102975 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI ABUBAKAR, AMINA, NEWTON, CHARLES · 2021 to 2025
$2.6M
NICHD NIH HHS R01 HD102975NIMH NIH HHS U01 MH119689Wellcome Trust
6 · The paper itself

Abstract

Neurodevelopmental disorders (NDDs) are a group of conditions with their onset during the early developmental period and include conditions such as autism and intellectual disability. Occurrence of NDDs is thought to be determined by both genetic and environmental factors, but data on the role of environmental factors for NDD in Africa is limited. This study investigates environmental influences on NDDs in children from Kenya. This case-control study compared children with NDDs and typically developing children from two studies on the Kenyan coast. We included 172 study participants from the Kilifi Autism study and 151 from the NeuroDev study who had a diagnosis of at least one NDD and 112 and 73 with no NDD diagnosis from each study, respectively. Potential risk factors were identified using unadjusted univariable analysis and adjusted multivariable logistic regression. Univariable analysis in the Kilifi Autism study sample revealed hypoxic-ischaemic encephalopathy conferred the largest odds ratio (OR) 10.52 [95%CI: 4.04, 27.41] for NDDs, followed by medical complications during pregnancy (gestational hypertension & diabetes, eclampsia, maternal bleeding) (OR=3.17 [95%CI: 1.61, 6.23]). In the NeuroDev study sample, labour and birth complications (OR=7.30 [95%CI 2.17, 24.61]), neonatal jaundice (OR=5.49 [95%CI 1.61,18.72]) and infection during pregnancy (OR= 5.31 [95%CI 1.56, 18.11]) conferred the largest risk associated with NDDs. In the adjusted analysis, seizures before age 3 years in the Kilifi Autism study and labour and birth complications in the NeuroDev study conferred the largest increased risk. Higher parity, the child being older and delivery at home were associated with a reduced risk for NDDs. Recognition of important risk factors such as labour and birth complications could guide preventative interventions, developmental screening of at-risk children and monitoring progress of these children. Further studies examining the aetiology of NDDs in population-based samples, including investigating the interaction between genetic and environmental factors, are needed.

Identifiers

PMID40445892
PMCPMC12124531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.